KIF20A Drives Anti-PD-1 Resistance in NSCLC
In the ever-evolving landscape of cancer immunotherapy, one of the most formidable challenges remains the innate resistance some tumors exhibit ...
In the ever-evolving landscape of cancer immunotherapy, one of the most formidable challenges remains the innate resistance some tumors exhibit ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine